TargeGen, Inc. is a privately held biopharmaceutical company based in San Diego. The Company combines a focus on vascular biology (Vasculostasis) with expertise in small molecule medicinal chemistry. TargeGen develops small-molecule drugs that suppress disease related changes in vascular permeability and vascular proliferation associated with ischemic diseases (such as heart attack and stroke) and cancer.
Business Sector: | Residential, Commercial |